Table 2 Prevalence of significant clinical signs by severity.
From: A proposed prognostic 7-day survival formula for patients with terminal cancer
Clinical signs | Training(n = 374) | Validation(n = 353) | P-value |
|---|---|---|---|
Cognitive | Â | Â | 0.014* |
   0 | 273 (73.0%) | 228 (64.6%) |  |
   1 to 3 | 101 (27.0%) | 125 (35.4%) |  |
Edema | Â | Â | 0.508 |
   0 | 190 (50.8%) | 188 (53.3%) |  |
   1 to 3 | 184 (49.2%) | 165 (46.7%) |  |
Jaundice | Â | Â | 0.747 |
   0 | 264 (70.6%) | 253 (71.7%) |  |
   1 to 3 | 110 (29.4%) | 100 (28.3%) |  |
ECOG score | Â | Â | <0.001* |
   1 and 2 | 167 (44.7%) | 26 (7.4%) |  |
   3 and 4 | 207 (55.3%) | 327 (92.6%) |  |
Ascites | Â | Â | <0.001* |
   0 | 218 (58.3%) | 265 (75.1%) |  |
   1 to 3 | 156 (41.7%) | 88 (24.9%) |  |